| Patents for C12R 1 - Micro-organisms (92,025) |
|---|
| 04/22/2003 | US6552169 Density enhanced protein tyrosine phosphatases |
| 04/22/2003 | US6551820 Transgenic plants capable of expressing immunogenic polypeptides, including hepatitis B antigen (HBsAg) in quantities sufficient to elicit an immune response in a human or animal that consumes all or a part of the plant |
| 04/22/2003 | US6551812 Diagnosing PPAR pathophysiologies, and identifying agents for treating these pathophysiologies, using nucleic acids whose expression changes following addition to cells of a ligand for PPAR |
| 04/22/2003 | US6551811 Protein comprises at least one site for N-linked glycosylation and is attached to a plasma membrane by a glycosylphosphatidylinositol radical |
| 04/22/2003 | US6551804 Generating 4-cyanopentanoic; obtain enzyme, immbolize, incubate with stabilizer, expose to 2-methylglutaronitrile, recover 4-cyanopentanoic acid |
| 04/22/2003 | US6551797 Expression system for producing proteins |
| 04/22/2003 | US6551773 Transcriptional co-repressor that interacts with nuclear hormone receptors and uses therefor |
| 04/22/2003 | CA2253636C Moraxella catarrhalis outer membrane protein-106 polypeptide, gene sequence and uses thereof |
| 04/22/2003 | CA2207741C Variants of human papilloma virus antigens |
| 04/22/2003 | CA2170757C Method of marking eukaryotic cells by the use of a cell surface receptor as a marker |
| 04/22/2003 | CA2163393C Amplification and detection of mycobacteria nucleic acids |
| 04/22/2003 | CA2137793C Crystallization of m-csf |
| 04/22/2003 | CA2096975C Cell stress transcriptional factors |
| 04/22/2003 | CA1341427C Variants of immunoglobulin gene superfamily member |
| 04/17/2003 | WO2003031601A1 Method of purifying mercury-contaminated material and microorganisms to be used therein |
| 04/17/2003 | WO2003030624A2 Hepatitis a virus nucleotide sequences, recombinant proteins and uses thereof |
| 04/17/2003 | WO2002083072A3 Methods and compositions for stable transgenic plant pharmaceuticals and their use as contraceptives |
| 04/17/2003 | WO2001072773A3 Genes isolated from dendritic cells, gene products and methods employing the same |
| 04/17/2003 | US20030074690 Novel plastid-targeting nucleic acid sequence, a novel beta-amylase sequence, a stimulus-responsive promoter and uses thereof |
| 04/17/2003 | US20030074684 Control of gene expression |
| 04/17/2003 | US20030073620 Genetic engineering; antibody binding to nucleic acid; disease therapy |
| 04/17/2003 | US20030073222 Multiply-substituted protease variants |
| 04/17/2003 | US20030073221 Hyaluronan synthase gene and uses thereof |
| 04/17/2003 | US20030073218 Enzyme inhibitor for us in the treatment and prevention of tumors |
| 04/17/2003 | US20030073203 Immobilized microorganism converts crotonobetaine as such, or its salts or derivatives, into L-carnitine in a continuously operating cell reactor, and ceramics, glass heads, polyurethane disk sare used as supports |
| 04/17/2003 | US20030073200 Generation of preferential polypeptide in cells; obtain cells, transfrom with vector coding preferential polypeptide, culture, express vector, recover polypeptides |
| 04/17/2003 | US20030072766 Comprising antiserum raised against a flagellaless Campylobacter strain for prophylaxis of Campylobacter colonisation in animals |
| 04/17/2003 | US20030072751 Idiotypic vaccination against b cell lymphoma |
| 04/17/2003 | US20030072726 Phenolic compounds from natural biological materials such as plant material |
| 04/16/2003 | EP1302541A1 Receptor protein specifically recognizing bacterial dna |
| 04/16/2003 | EP1302447A2 Process for the treatment of aqueous effluents containing methyl tert-butyl ether and/or methyl tert-amyl ether by mycobacterium austroafricanum I-2562 |
| 04/16/2003 | EP1302207A2 Method for preparing an antihypertensive agent containing a dipeptide as active ingredient |
| 04/16/2003 | EP1301617A2 Process for generation of hydrogen gas from various feedstocks using thermophilic bacteria |
| 04/16/2003 | EP1301592A2 Recombinant bacterial phytases and uses thereof |
| 04/16/2003 | EP1301591A1 Methods and compositions for rapid protein and peptide extraction and isolation using a lysis matrix |
| 04/16/2003 | EP1301587A1 Method for culturing micro-organisms in reducing conditions obtained by a gas stream |
| 04/16/2003 | EP0871483B1 Helper virus-free aav production |
| 04/16/2003 | EP0868522B1 Recombinant poxvirus-feline infectious peritonitis virus, compositions thereof and methods for making and using them |
| 04/16/2003 | EP0746611B1 Method for increasing production of disulfide bonded recombinant proteins by (saccharomyces cerevisiae) |
| 04/16/2003 | EP0654083B1 Ptp-d subfamily of protein tyrosine phosphatases |
| 04/16/2003 | EP0648271B1 Adenovirus mediated transfer of genes to the gastrointestinal tract |
| 04/16/2003 | EP0642356B1 Antibodies to p-selectin and their uses |
| 04/16/2003 | EP0605442B1 Recombinant antibodies for human therapy |
| 04/16/2003 | EP0591462B1 Universal donor cells |
| 04/16/2003 | EP0570506B1 Bacillus thuringiensis isolates |
| 04/16/2003 | CN1411506A Nitrilase from rhodococcus rhodochrous NCIMB 11216 |
| 04/16/2003 | CN1411468A Attenuated microorganisms for treatment of infection |
| 04/16/2003 | CN1105778C Process for producing nucleoside-5'-phosphate |
| 04/16/2003 | CA2400265A1 Enzyme solution for culturing primate embryonic stem cells and method of culturing using it |
| 04/15/2003 | US6548735 5'-flanking sequence such as beta-lactoglobulin and DNA coding for a serine protease such as alpha1-antitrypsin or a blood factor |
| 04/15/2003 | US6548655 Interleukin-4 receptors |
| 04/15/2003 | US6548297 Sheets are frozen in cryoprotectant solution of mono-/di-saccharide; eliminates need to wash cryopreserved components; materials handling |
| 04/15/2003 | US6548291 Polynucleotide sequences/transgenic cells of Bacillus thuringiensis |
| 04/15/2003 | US6548288 Inoculating mixture of microbes as main components in rice bran medium to obtain bacteria by subculture; inoculating bacteria in a culture medium of crushed soil from volcanic rocks mineral, nutrients, water; culturing; air ventilation |
| 04/15/2003 | US6548285 Polynucleotides encoding Aspergillus Niger and Penicillium Chrysogenum acetamidases and methods of use as selectable markers |
| 04/15/2003 | US6548277 Method for molecular cloning and polynucleotide synthesis using vaccinia DNA topoisomerase |
| 04/15/2003 | US6548253 Method of isolating plasmid DNA |
| 04/15/2003 | US6548067 Antigenic constructs of major histocompatibility complex class I antigens with specific carrier molecules, the preparation and use thereof |
| 04/15/2003 | US6548057 Bifidobacterium breve ferm BP 6223 for producing fermented soymilk |
| 04/15/2003 | CA2257101C Dna sequences encoding phytases of ruminal microorganisms |
| 04/15/2003 | CA2034504C Fungal stress proteins |
| 04/10/2003 | WO2003029484A2 Antimicrobial methods and materials |
| 04/10/2003 | WO2003029456A1 Multi-chain eukaryotic display vectors and uses thereof |
| 04/10/2003 | WO2003008575A3 Dna sequences for regulating transcription |
| 04/10/2003 | WO2002059290A3 A method for evolving a cell having desired phenotype and envolved cells |
| 04/10/2003 | WO2002057476A9 Methods and microorganisms for the production of 3-(2-hydroxy-3-methyl-butyrylamino)-propionic acid (hmbpa) |
| 04/10/2003 | WO2002042842A3 A high-throughput screen for identifying channel blockers that selectively distinguish transient from persistent sodium channels |
| 04/10/2003 | WO2002030440A1 Medicinal compositions for promoting recovery from stress loading and novel matsutake mushroom strain |
| 04/10/2003 | WO2001083800A3 Heterologous production of polyketides |
| 04/10/2003 | US20030070190 Methods for increasing stearate content in soybean oil |
| 04/10/2003 | US20030069409 T1-R ligand III |
| 04/10/2003 | US20030069204 Strain of streptomyces |
| 04/10/2003 | US20030069201 Methods of using BCL-2 for the therapeutic treatment and prevention of diseases |
| 04/10/2003 | US20030069193 Has an activity against MRSA (methicillin-resistant Staphylococcus aureus). |
| 04/10/2003 | US20030068811 Generation of therapeutic agent for the treatment of alzheimer's disease; obtain chemical intermediates, reduce with oxidoreductase, recover therapeutic agent |
| 04/10/2003 | US20030068677 Recombinant production of novel polyketides |
| 04/10/2003 | US20030068674 Method of producing a biosensor protein capable of regulating a fluorescence property of green fluorescent protein, and the biosensor protein produced by the method |
| 04/10/2003 | US20030068672 Nucleotide sequences coding polypeptide for use in the treatment of psychological, respiratory, cardiovascular and pain disorders |
| 04/10/2003 | US20030068612 Reverse two-hybrid systems |
| 04/10/2003 | US20030068323 Hybrid compositions for intracellular targeting |
| 04/10/2003 | CA2462113A1 Multi-chain eukaryotic display vectors and uses thereof |
| 04/10/2003 | CA2425361A1 Pharmaceutical composition for promoting a recovery from stress and novel tricholoma matsutake strain |
| 04/09/2003 | EP1300471A1 Nutritional mixture and method for early identification and count of gram-negative organisms |
| 04/09/2003 | EP1300468A2 TRNA synthetase |
| 04/09/2003 | EP1300156A2 Otitis media vaccine |
| 04/09/2003 | EP1299552A2 Methods and compositions for simultaneous saccharification and fermentation |
| 04/09/2003 | EP1140885B1 Method for high yield extraction of paclitaxel from paclitaxel-containing material |
| 04/09/2003 | EP1049794B1 Method for producing l-carnitine from crotonobetaine |
| 04/09/2003 | EP0840748B1 Transforming growth factor beta crystals |
| 04/09/2003 | EP0784685B1 Chicken anemia virus mutants and vaccines and uses based on the viral proteins vp1, vp2 and vp3 or sequences of that virus coding therefor |
| 04/09/2003 | EP0722462B1 Dna encoding prostaglandin receptor ip |
| 04/09/2003 | EP0708834B1 Formation of and methods for the production of large (bacillus thuringiensis) crystals with increased pesticidal activity |
| 04/09/2003 | EP0708831B1 Cell-density enhanced protein tyrosine phosphatases |
| 04/09/2003 | EP0675956B1 New protein from urine named component b |
| 04/09/2003 | CN1409769A Method for continuous cultivation of microorganisms of genus eremothecium |
| 04/09/2003 | CN1409755A Production of peptides by fedbatch cultivation of microoganism |
| 04/09/2003 | CN1408878A process for preparing L-glutamic acid |
| 04/09/2003 | CN1105211C Method for providing cellulose raw material with improved strengh and/or shape keeping property and/or anti-crease property and cellulose material produced thereof |
| 04/09/2003 | CN1105187C Protocadherin proteins and their use |
| 04/09/2003 | CN1105186C Gene imparting flocculability to yeast and gene product |